To access the results of clinical trials, researchers use “endpoints,” specific events or outcomes that help evaluate the benefit of the intervention under investigation. Traditionally, overall ...

Cardiovascular disease remains the leading global killer. Still, too many late-stage cardiology trials stumble, not for lack of biology, but because episodic, clinic-bound measures miss what matters ...

In today's ACT Brief, we explore how Bayesian approaches are powering studies in rare disease and pediatrics, a major public-private initiative is standardizing digital endpoints for regulatory ...

Clinical trials remain the cornerstone of evidence-based medicine, with composite endpoints playing an increasingly pivotal role in assessing the efficacy and safety of new interventions. Composite ...

Less than half of the recent trials testing therapies for atherosclerotic cardiovascular disease (ASCVD) use the same endpoint, and many alter those endpoints after enrollment begins, according to a ...

Public-private collaboration and structured evidence consolidation are emerging as critical enablers of regulatory-ready digital endpoints, helping standardize terminology, reduce duplication, and ...

GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video from the American Academy of Ophthalmology meeting, Lejla Vajzovic, MD, FASRS, ...

Please provide your email address to receive an email when new articles are posted on . Topline results from the phase 3 ReThink-ALZ study of simufilam in mild to moderate Alzheimer’s disease showed ...

In recent years, a growing number of clinical trials have used composite endpoints—multiple events all treated as one endpoint—as a way to boost the power of a study so that fewer participants are ...